Elk Grove, CA, United States of America

Brian Gorre-Clancy


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Brian Gorre-Clancy: Innovator in Beta-Glucosidase Variants

Introduction

Brian Gorre-Clancy is a prominent inventor based in Elk Grove, California, known for his significant contributions to the field of biotechnology. With a total of three patents to his name, Gorre-Clancy specializes in the development of innovative variants of beta-glucosidases, which are essential enzymes in various biochemical processes.

Latest Patents

Among his latest patents, Brian Gorre-Clancy has developed variants of beta-glucosidase that include specific substitutions at critical amino acid positions. These innovations, detailed in his patent filings, include variants comprising substitutions at positions 142, 183, 266, and 703 of amino acids 1 to 842 of SEQ ID NO: 2, or corresponding positions in SEQ ID NO: 70. Each variant demonstrates beta-glucosidase activity, which is crucial for numerous applications in biotechnology. Furthermore, the inventions encompass nucleotide sequences encoding these variants, as well as associated nucleic acid constructs, vectors, and host cells.

Career Highlights

Brian Gorre-Clancy is currently affiliated with Novozymes, Inc., a leading company in the biotechnology sector that specializes in enzyme production. His work at Novozymes has allowed him to pioneer innovations that enhance the effectiveness of beta-glucosidases in various industries, thereby contributing significantly to advancements in enzyme technology.

Collaborations

In his professional journey, Brian collaborates with esteemed colleagues, including Ana Fidantsef and Michael Lamsa. These collaborations have fostered a dynamic environment for research and innovation, furthering the development of groundbreaking biotechnological solutions.

Conclusion

Brian Gorre-Clancy’s contributions to the field of biotechnology, particularly through his patented innovations in beta-glucosidase variants, highlight his role as an influential inventor. His ongoing work at Novozymes and collaborations with fellow innovators underscore the importance of teamwork in driving advancements in enzyme technology. As biotechnology continues to evolve, Gorre-Clancy’s creations will likely play a pivotal role in shaping future developments in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…